Therapeutic Efficacy of Intratendinous Delivery of Dexamethasone Using Porous Microspheres for Amelioration of Inflammation and Tendon Degeneration on Achilles Tendinitis in Rats

Figure 2

(a) Cytotoxicity of PMSs, DEX (1%)/PMSs, DEX (5%)/PMSs, and DEX (10%)/PMSs at 24 and 48 hr. (b) Cumulative dexamethasone release from DEX (1%)/PMSs, DEX (5%)/PMSs, and DEX (10%)/PMSs. The error bars are presented as the standard deviation of measurements for 10 mg PMSs with or without DEX in each group (n = 4).

(a)

(b)